Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Rheumatology · Giant Cell Arteritis

Building Your Multidisciplinary Care Team

At a Glance

Disseminated visceral or large-vessel giant cell arteritis can affect multiple arteries and organs, so care is coordinated across rheumatology, vascular surgery, imaging, primary care, and organ specialists. Bring scans, pathology materials, and a treatment timeline to second-opinion visits.

Because disseminated visceral GCA affects multiple internal organ systems, it is rarely managed by a single doctor. Your care often benefits from a multidisciplinary team—a group of specialists from different fields who work together to coordinate your treatment [1][2].

Think of this team like a network: while a primary captain directs care, they regularly pull in specialized expertise to protect your overall health.

Your Care Network: The Key Specialists

A complex case of systemic or large-vessel GCA typically involves several key players [3][4]:

  • The Rheumatologist (The Captain): This is the specialist who manages your immune system. You should look for someone with specific experience in large-vessel vasculitis (LV-GCA), as this requires different monitoring than the more common “cranial” form [5][6].
  • The Vascular Surgeon: They monitor the physical structure of your arteries. They are responsible for evaluating any aneurysms or blockages and deciding if or when a procedure like a stent or bypass is needed [7][8].
  • The Radiologist & Nuclear Medicine Specialist: These experts interpret your PET-CT, MRA, and CTA scans. In a specialized center, these doctors have specific training in identifying the subtle signs of “vessel wall inflammation” [1][9].
  • Organ Specialists: Depending on where your inflammation is located, you may occasionally need a Cardiologist (for heart/aorta involvement), a Gastroenterologist (for intestinal/liver involvement), or a Nephrologist (for kidney artery involvement) [2][10].
  • The Primary Care Physician: They play a vital role in managing the “side effects” of your treatment, such as monitoring your bone density, blood sugar, and vaccinations while you are on immunosuppressants [2].

Seeking a Second Opinion: What to Bring

If you are seeking a second opinion—which is common and often helpful for rare variants like this—you can help by acting as your own “medical librarian.” Specialized vasculitis centers often need the raw data, not just the summaries, to give you an accurate assessment [9][11].

Helpful Records to Gather:

  1. Imaging Discs (DICOM files): Try to provide the actual digital images (usually on a CD or via a secure cloud link) for every PET-CT, CTA, and MRA you have had. Specialists prefer to see the raw files to compare old and new scans themselves [11][12].
  2. Pathology Slides: If you have had a biopsy (temporal artery, aortic wall, or an organ resection), the second-opinion center may request the glass pathology slides or paraffin blocks. A specialized vascular pathologist may see details that a general pathologist might miss [13][14].
  3. The Treatment Timeline: Create a simple document that lists every medication you have taken, the exact date you started it, and any changes in your dose. It is especially important for doctors to know if you were on steroids at the time of your PET-CT, as this can change how they interpret the results [15][16].

Evaluating Expertise

When meeting a new specialist, it is okay to be direct about their experience with this rare phenotype. Because standard GCA is already rare, and the internal/large-vessel version is even rarer, many general rheumatologists may only see one case every few years [17].

A highly experienced center will sometimes participate in multidisciplinary vascular conferences, where rheumatologists, surgeons, and radiologists meet to discuss complex cases like yours [18][19]. Finding a team that uses a collaborative approach is an excellent way to ensure your internal organs are being protected from every angle [3].

Common questions in this guide

What specialists are usually involved in caring for large-vessel giant cell arteritis?
A rheumatologist often helps coordinate care, especially one experienced with large-vessel disease. A vascular surgeon and specialists who review scans may be involved, along with a cardiologist, gastroenterologist, or nephrologist when particular organs or arteries are affected. Primary care can monitor issues such as bone health, blood sugar, and vaccinations during treatment.
Why does disseminated visceral GCA require a multidisciplinary team?
Because inflammation can affect several large blood vessels and internal organs, one clinician may not cover every part of care. A coordinated team can combine immune-disease management, artery assessment, imaging review, organ-specific care, and monitoring for treatment effects.
What should I bring to a second-opinion appointment for large-vessel GCA?
Bring the original digital images from your PET-CT, CTA, and MRA scans, not only written reports. If you had a biopsy or surgery, ask whether the center needs the glass slides or paraffin blocks. Also bring a dated list of medicines, doses, and changes, including steroid use around each scan.
How can I find a specialist with experience in extracranial GCA?
Ask how often the clinician or center manages large-vessel or extracranial GCA and whether it can consult vascular surgeons and imaging experts. Centers that hold multidisciplinary vascular conferences may offer a collaborative way to review complex cases.
Who should coordinate my different GCA specialists?
Ask your clinicians to identify one primary care coordinator, sometimes called the care captain. This is often the rheumatologist, but the arrangement can vary; the important point is that one person tracks recommendations, testing, and follow-up across the team.
Can steroid treatment affect how my scans are interpreted?
Yes. Steroids can change the amount of inflammation visible on imaging, so specialists need to know when you started treatment and what dose you were taking when each scan was performed. Keep a dated treatment timeline and share it with the reviewing team.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on disseminated visceral giant cell angiitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with 'extracranial' or 'large-vessel' GCA do you typically manage in your practice?
  2. 2.Does your clinic have access to vascular surgeons and radiologists for consultations on complex cases?
  3. 3.Who is my primary 'care captain' who will coordinate all these different specialist recommendations?
  4. 4.If I need a second opinion at a specialized vasculitis center, will you help coordinate the transfer of my digital imaging files and pathology slides?

References

References (19)
  1. 1

    Diagnostic and Therapeutic Challenges of Vasculitis.

    Hansen ME, Springer J, Byram K

    The Canadian journal of cardiology 2022; (38(5)):623-633 doi:10.1016/j.cjca.2022.02.007.

    PMID: 35157989
  2. 2

    Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis.

    Morales E, Rúa-Figueroa I, Callejas Rubio JL, et al.

    Nefrologia 2025; (45(1)):15-58 doi:10.1016/j.nefroe.2025.01.001.

    PMID: 39855968
  3. 3

    Aortitis as a High-Risk Vascular Syndrome: Integrating Phenotype-Driven Diagnosis, Multidisciplinary Assessment, and Personalised Management.

    Georghiou GP, Socratous K, Kyriakou S, et al.

    Journal of personalized medicine 2026; (16(8)) doi:10.3390/jpm16080430.

    PMID: 42645924
  4. 4

    Multi-Modality Imaging in Vasculitis.

    Allam MN, Baba Ali N, Mahmoud AK, et al.

    Diagnostics (Basel, Switzerland) 2024; (14(8)) doi:10.3390/diagnostics14080838.

    PMID: 38667483
  5. 5

    Large vessel giant cell arteritis.

    van der Geest KSM, Sandovici M, Bley TA, et al.

    The Lancet. Rheumatology 2024; (6(6)):e397-e408 doi:10.1016/S2665-9913(23)00300-4.

    PMID: 38574745
  6. 6

    Large-vessel vasculitis.

    Pugh D, Karabayas M, Basu N, et al.

    Nature reviews. Disease primers 2022; (7(1)):93 doi:10.1038/s41572-021-00327-5.

    PMID: 34992251
  7. 7

    [Aortitis in giant cell arteritis: Diagnosis, prognosis and treatment].

    Enfrein A, Espitia O, Bonnard G, Agard C

    Presse medicale (Paris, France : 1983) 2019; (48(9)):956-967 doi:10.1016/j.lpm.2019.04.018.

    PMID: 31327542
  8. 8

    An Updated Review of Cardiovascular Events in Giant Cell Arteritis.

    de Boysson H, Aouba A

    Journal of clinical medicine 2022; (11(4)) doi:10.3390/jcm11041005.

    PMID: 35207277
  9. 9

    EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update.

    Dejaco C, Ramiro S, Bond M, et al.

    Annals of the rheumatic diseases 2024; (83(6)):741-751 doi:10.1136/ard-2023-224543.

    PMID: 37550004
  10. 10

    Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

    Misra DP, Shenoy SN

    Rheumatology international 2017; (37(1)):151-167 doi:10.1007/s00296-016-3435-1.

    PMID: 26886388
  11. 11

    The Role of FDG-PET in the Diagnosis and Monitoring of Large-Vessel Vasculitis.

    Tomelleri A, Campochiaro C, Grayson PC, Quinn KA

    Current rheumatology reports 2025; (27(1)):40 doi:10.1007/s11926-025-01204-w.

    PMID: 41269401
  12. 12

    Recent advances in the diagnosis and therapy of large vessel vasculitis.

    Keser G, Atagunduz P, Soy M

    Polish archives of internal medicine 2022; (132(6)) doi:10.20452/pamw.16272.

    PMID: 35699647
  13. 13

    Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy.

    Fukami Y, Koike H, Katsuno M

    Expert review of neurotherapeutics 2022; (22(11-12)):941-952 doi:10.1080/14737175.2022.2166831.

    PMID: 36609209
  14. 14

    Treatment of giant cell arteritis - current approach and new possibilities.

    Videman J, Skácelová M, Horák P, et al.

    Vnitrni lekarstvi 2022; (68(5)):266-272 doi:10.36290/vnl.2022.058.

    PMID: 36283815
  15. 15

    Imaging in Giant Cell Arteritis.

    Khan A, Dasgupta B

    Current rheumatology reports 2015; (17(8)):52 doi:10.1007/s11926-015-0527-y.

    PMID: 26113013
  16. 16

    Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.

    Nielsen BD, Gormsen LC, Hansen IT, et al.

    European journal of nuclear medicine and molecular imaging 2018; (45(7)):1119-1128 doi:10.1007/s00259-018-4021-4.

    PMID: 29671039
  17. 17

    [A rarely recognized cause of cerebral ischemia: cerebral angiitis].

    Papp A, Varga V, Zaja G, et al.

    Orvosi hetilap 2025; (166(23)):887-906 doi:10.1556/650.2025.33307.

    PMID: 40483677
  18. 18

    A case of large-vessel giant cell arteritis onset in a patient over 90 years old: Diagnostic challenge in differentiating from an infectious aneurysm.

    Oyama Y, Okawa K, Sakai T, et al.

    Journal of cardiology cases 2026; (33(3)):63-66 doi:10.1016/j.jccase.2025.11.007.

    PMID: 41789021
  19. 19

    Imaging in Large Vessel Vasculitis-A Narrative Review.

    Popescu I, Pintican R, Cocarla L, et al.

    Journal of clinical medicine 2024; (13(21)) doi:10.3390/jcm13216364.

    PMID: 39518503

This page is for informational purposes only and does not constitute medical advice about large-vessel or disseminated visceral GCA. Ask your rheumatologist and other clinicians to tailor your care team and records plan to your situation.